Trials / Recruiting
RecruitingNCT03185468
Intervention of Bladder Cancer by CAR-T
Intervention of Advanced or Metastatic Urothelial Bladder Cancer by 4SCAR-T Cell Therapies
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Shenzhen Geno-Immune Medical Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase I/II and multicenter study designed to evaluate the efficacy and safety of 4SCAR-T cells in participants with locally advanced or metastatic urothelial bladder cancer (UBC) who have no further treatment available.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | 4SCAR-PSMA | PSMA-specific 4th Generation CART |
| GENETIC | 4SCAR-FRa | FRa-specific 4th Generation CART |
Timeline
- Start date
- 2025-08-01
- Primary completion
- 2028-12-31
- Completion
- 2029-12-31
- First posted
- 2017-06-14
- Last updated
- 2025-09-08
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03185468. Inclusion in this directory is not an endorsement.